CORVUS PHARMACEUTICALS
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
CORVUS PHARMACEUTICALS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2014-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.corvuspharma.com
Total Employee:
51+
Status:
Active
Contact:
+1 650 900 4520
Total Funding:
215.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Domain Not Resolving Apache
Similar Organizations
Ablaze Pharmaceuticals
Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.
Acerus Pharmaceuticals
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company.
Actimed Therapeutics
Actimed Therapeutics is a clinical stage biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cycle Pharmaceuticals
Cycle Pharmaceuticals is a pioneering pharmaceutical company.
Halia Therapeutics
Halia is a preclinical-stage biopharmaceutical company.
Innogen Pharmaceutical
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing and R&D company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Purple Biotech
Purple Biotech is an innovative biopharmaceutical drug development company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Oxeia Biopharmaceuticals
Oxeia Biopharmaceuticals is a clinical stage biotech company.
SELLAS Life Sciences
SELLAS Life Sciences is a late-stage biopharmaceutical company.
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
UroGen Pharma
UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.
Vyriad
Vyriad is a clinical stage biopharmaceutical company.
Zhaoke Ophthalmology Pharmaceutical
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
Current Advisors List
Board_member
2016-03-01
Board_member
Current Employees Featured
Joseph J Buggy Co-Founder @ Corvus Pharmaceuticals
Co-Founder
Richard A Miller Co-Founder & CEO @ Corvus Pharmaceuticals
Co-Founder & CEO
James Rosenbaum Senior Vice President of Research @ Corvus Pharmaceuticals
Senior Vice President of Research
2022-01-01
Founder
Stock Details
Investors List
Richard A Miller
Richard A Miller investment in Post-IPO Equity - Corvus Pharmaceuticals
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Corvus Pharmaceuticals
OrbiMed
OrbiMed investment in Series B - Corvus Pharmaceuticals
Adams Street Partners
Adams Street Partners investment in Series B - Corvus Pharmaceuticals
BlackRock
BlackRock investment in Series B - Corvus Pharmaceuticals
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Corvus Pharmaceuticals
Novo Ventures
Novo Ventures investment in Series B - Corvus Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Series B - Corvus Pharmaceuticals
OrbiMed
OrbiMed investment in Series A - Corvus Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-21 | Corvus Pharmaceuticals Appoints Dr. James Rosenbaum Senior Vice President of Research |
Official Site Inspections
http://www.corvuspharma.com Semrush global rank: 742.59 K Semrush visits lastest month: 54.57 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Corvus Pharmaceuticals"
Leadership | Corvus Pharmaceuticals
Mr. Morrison previously served on the boards of directors of the Life Sciences Foundation, a biotechnology nonprofit organization, the Bay Area Biosciences Association, a 501(c)(3) organization, and the Emerging Companies Section …See details»
About Us | Corvus Pharmaceuticals
Founded in 2014, Corvus has rapidly developed a deep pipeline of potentially breakthrough investigational medicines designed to be potent, selective and convenient to administer.See details»
Corvus Pharmaceuticals - Crunchbase Company Profile …
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune …See details»
Stockholder Overview | Corvus Pharmaceuticals
Mar 17, 2025 Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025. Mar 12, 2025See details»
Corvus Pharmaceuticals Company Profile | Management and
Www.corvuspharma.com Corvus Pharmaceuticals Profile and History Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and …See details»
Corvus Pharmaceuticals - Overview, News & Similar companies
May 10, 2024 Corvus Pharmaceuticals contact info: Phone number: (650) 900-4520 Website: www.corvuspharma.com What does Corvus Pharmaceuticals do? Corvus Pharmaceuticals is …See details»
Corvus Pharmaceuticals
Mar 2, 2025 https://www.corvuspharma.com Dive deeper into fresh insights across Business , Industry Leaders and Influencers , Organizations , Education , and Investors for a …See details»
Corvus Pharmaceuticals - The Org
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.See details»
Corvus Pharmaceuticals Company Overview, Contact Details
May 2, 2024 Corvus Pharmaceuticals, Inc. launched update on CPI-818 data on Dec 5th '22. Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage …See details»
Corvus Pharmaceuticals Overview | SignalHire Company Profile
Corvus Pharmaceuticals is a public company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. …See details»
Corvus Pharmaceuticals - Craft
Oct 29, 2024 Net income (Q3, 2024)($40.2M) Cash (Q3, 2024)$4.7M EBIT (Q3, 2024)($7.3M) Enterprise value $552.1MSee details»
Stockholder Overview | Corvus Pharmaceuticals
Jan 13, 2025 Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies with the potential to significantly improve the treatment of immune diseases …See details»
Corvus Pharmaceuticals, Inc. (Corvus Pharmaceuticals, Inc.) - 药物 …
The Company’s lead product candidate is soquelitinib, an investigational, oral, small molecule drug that selectively inhibits ITK. Its other clinical-stage candidates are being developed for a …See details»
Corvus Pharmaceuticals - News, Partnerships, Locations and …
Usearch identified 1 signals for Corvus Pharmaceuticals, including: 1 Partnerships. Usearch discovered 1 location for Corvus Pharmaceuticals including locations in Burlingame · …See details»
Director/Senior Director of Clinical Development in Immune …
Represent the organization at scientific conferences, advisory boards, and industry events. Collaborate with internal teams, including R&D, medical affairs, and commercial teams, to …See details»
Corvus Pharmaceuticals Provides Business Update and Reports …
Dec 31, 2024 For more information, visit www.corvuspharma.com. About Soquelitinib Soquelitinib (formerly CPI-818) is an investigational small molecule drug given orally designed …See details»
Corvus Pharmaceuticals to Provide Business Update and Third …
Nov 5, 2024 Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PTBURLINGAME, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, …See details»
Our Approach | Corvus Pharmaceuticals
Our approach to developing cancer medicines includes combining rigorous science and clinical research with development of biomarkers that potentially allow us to better select the optimum …See details»
Corvus Pharmaceuticals Provides Business Update and Reports …
10 hours ago llea@corvuspharma.com. MEDIA CONTACT: Sheryl Seapy Real Chemistry +1-949-903-4750 sseapy@realchemistry.comSee details»
Our Pipeline | Corvus Pharmaceuticals
Soquelitinib (CPI-818) Soquelitinib is an oral, small molecular drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase) and has the potential to provide a platform opportunity …See details»